FdaApplication
ANDA 214091
Identifiers
- fda_app_no: ANDA214091
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2021-10-05 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE;ORAL |
| CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE;ORAL |
2 products